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Age-related deficits in the immune system have been associated with an increased
incidence of infections, autoimmune diseases, and cancer. Human B cell populations
change quantitatively and qualitatively in the elderly. However, the function of
human B-1 cells, which play critical anti-microbial and housekeeping roles, have
not been studied in the older age population. In the present work, we analyzed
how the frequency, function and repertoire of human peripheral blood B-1 cells
(CD19+CD20+CD27+CD38low/intCD43+) change with age. Our results show that not
only the percentage of B-1 cells but also their ability to spontaneously secrete IgM
decreased with age. Further, expression levels of the transcription factors XBP-1 and
Blimp-1 were significantly lower, while PAX-5, characteristic of non-secreting B cells, was
significantly higher, in healthy donors over 65 years (old) as compared to healthy donors
between 20 and 45 years (young). To further characterize the B-1 cell population in
older individuals, we performed single cell sequencing analysis of IgM heavy chains from
healthy young and old donors. We found reduced repertoire diversity of IgM antibodies in
B-1 cells from older donors as well as differences in usage of certain VH and DH specific
genes, as compared to younger. Overall, our results show impairment of the human B-1
cell population with advancing age, which might impact the quality of life and onset of
disease within the elderly population.
Keywords: human B-1 cells, aging, IgM, antibody secretion, repertoire
INTRODUCTION
Life expectancy is rapidly increasing worldwide. However, age-related diseases such as
atherosclerosis, cancer, autoimmunity, type-2 diabetes mellitus, and microbial infection still have
an impact on morbidity and mortality of elderly adults. Further, aging is accompanied by broad
structural and functional changes in the immune system, usually related to increased susceptibility
to the aforementioned diseases (1) and to decreased response to vaccination (2, 3).
It has been demonstrated that advancing age exerts a strong influence on remodeling of the B
cell compartment of the immune system [reviewed in (4)]. There are two primary branches within
the B cell population: conventional B-2 cells and B-1 cells. In mice, B-1 and B-2 cells differ in
function and development, with B-2 cells originating mainly from the bone marrow and B-1 cells
mainly from fetal liver and to a lesser extent from adult bone marrow (5, 6). Conventional B-2
cells cooperate with T cells in the germinal center to provide high-affinity long lasting antibody
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responses (7). On the other hand, B-1 cells spontaneously secrete
natural antibodies mainly against non-protein antigens in the
absence of exogenous immunization. This feature allows B-1
cells to provide pre-existing, immediate defense to counteract
microbial infection (8–10). Given that B-1 cells are among the
first B cells to develop, and the fact that B-1 cells, particularly
IgM-secreting B-1 cells, are already present before birth, B-1
cells may be considered as the principal B cells responsible for
establishing a natural antibody repertoire and defense early in
ontogeny. Furthermore, it has been suggested that the earliest
waves of B-1 cells during ontogeny produce natural IgM that
regulates both B-1 and B-2 cell development (11). Also, B-
1 cell antibodies influence some chronic diseases, such as
atherosclerosis [reviewed in (12)].
Unlike high-affinity antibodies produced by B-2 cells,
antibodies secreted by B-1 cells in mice have a germ-line like
structure, due to minimal insertion of non-template-encoded
nucleotides (N-region addition) and little somatic hypermutation
(13, 14). B-1 cell-derived antibodies are often autoreactive, and
serve a homeostatic function in speeding disposal of apoptotic
cell debris and noxious molecular species [reviewed in (15)]. As
such, B-1 cell antibodies can protect against atherosclerosis and
autoimmunity (16, 17). Further, B-1 cells are considered more
effective antigen presenting cells (APCs) than B-2 cells, and B-
1 cells, but not B-2 cells, stimulate CD4+ T cells to differentiate
into Th17 effector cells (18).
In humans, B-1 cells have been identified as
CD20+CD27+CD38low/intCD43+ based on the fact that
B cells with this phenotype fulfill key functional criteria
characteristic of mouse B-1 cells, such as spontaneous antibody
secretion (19, 20). This population has been evaluated in healthy
donors and in patients with autoimmune diseases, suggesting a
role for human B-1 cells in such situations (21). For example,
the frequency of B-1 cells in patients with relapsing-remitting
multiple sclerosis was decreased compared with healthy controls
(22). Also, the human B cell population with the phenotype
CD20+CD27+CD43+CD5- generates antibodies to capsular
polysaccharides of Streptococcus pneumoniae (23) suggesting an
important role of this population in fighting infection.
Several reports have shown changes in conventional B-
2 cells during aging, both in mice and humans. There is a
decline in total B cell number or frequency during aging,
which is more clearcut in humans than in mice (4). Further,
the proportion of different subtypes within the B-cell lineage
changes with age. For example, marginal zone (MZ) B cells
significantly decline in aged BALB/c mice (24) while there
is an increase in age-associated B cells (ABCs) (25). This is
more controversial in the human scenario: different subsets
of B cells have been shown to increase or decrease during
aging depending on the cell phenotype or age of the cohort
(26, 27). Functionally, aging impacts the mature B cell antibody
response to vaccination. After antigenic challenge, B cells
from old individuals produce fewer antibodies (28) and are
impaired in the ability to undergo class switch recombination
(CSR) (29, 30) and somatic hypermutation (SHM) (31), as
compared to young individuals. This is compounded by
loss of diversity in the B cell repertoire (32). As a result,
antibodies generated in both old mice and old humans are less
protective compared with antibodies produced by young adults
(33, 34).
On the other hand, the impact of aging on the frequency and
function of B-1 cells has been less studied. Themost noted feature
of B-1 cells in the aging mouse immune system is a change in
repertoire. For example, certain VH11-encoded PtC-binding IgH
sequences increase progressively with age in the pre-immune B-
1a IgH repertoire (35). Other important specificities of B-1 cells
are phosphorylcholine (PC) (36) and pneumococcal capsular
polysaccharides, antigens found on the cell walls of the bacteria
Streptococcus pneumoniae (10, 37). These bacteria are responsible
for pneumococcal infections which are dramatically increased in
old relative to young adults (38). The importance of B-1a cells
in protection against pneumococci is indicated by experiments
showing that in the absence of B-1a cells animals were unable to
survive infection because of the lack of natural IgM, especially
anti-PC and anti-pneumococcal capsular polysaccharide (PPS)-
3 (10). Natural anti-pneumococcal antibodies produced by B-
1 cells are increasingly important in aging since in the old
population the adaptive anti-pneumococcal antibody response
generated after immunization is less protective both in mice and
humans (38–42). However, it has been shown that protection
afforded by natural serum IgM against pneumococcal infection in
mice diminishes with advancing age (43). B-1 cells isolated from
old mice produce antibodies with more N-addition than B-1 cells
from young animals (43–45), which can contribute to the above
mentioned impaired protection. Still, a comprehensive study of
changes in human B-1 cells during normal aging is lacking.
In the current work we elucidated age-related changes in
the human B-1 cell population. We found B-1 cell frequency
significantly decreases with advancing age. Functional analysis
showed the B-1 cell population from older donors contains fewer
antibody secreting cells than does the B-1 cell population present
in younger donors. Further, we found transcription factors
involved in the “classical” immunoglobulin secretion pathway are
differentially expressed in B-1 cells from young and old donors.
Importantly, we found reduced IgM repertoire diversity in B-1
cells from older as compared to younger donors. However, there
were no differences in B-1 cell IgM somatic hypermutation or N-
addition between young and old donors. Thus, with advancing
age there are fewer B-1 cells, a smaller fraction of which
secrete IgM, that display diminished diversity. Overall, these data
indicate a decline in B-1 cell functionality in older individuals
that might compromise the ability to oppose age-related diseases
such as microbial infection and atherosclerosis.
MATERIALS AND METHODS
Human Samples
Adult peripheral blood samples were obtained by venipuncture
from a total of 120 healthy donors (20–88 years), of which 58%
were females and 42% males. Donors were selected on the basis
of good health status and no reports of infection/immunization
within 4 weeks of blood draws. This study was conducted in
accordance with the World Medical Association’s Declaration of
Helsinki.Written informed consent was received from all donors.
This study was approved by the North Shore-LIJ Health System
Institutional Review Board.
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Cell Isolation
Heparinized blood samples were processed immediately
upon receipt. Human peripheral blood mononuclear cells
(PBMCs) were isolated by density gradient centrifugation using
lymphocyte separation medium (Cellgro). Mononuclear cells
were washed in phosphate-buffered saline (PBS) containing
1mM EDTA and resuspended in either cell-sorting buffer [0.5%
bovine serum albumin (BSA) in PBS] or FACS buffer [2.5% fetal
calf serum (FCS), 1mM EDTA, 0.02% NaN3 in PBS].
Cell Sorting
PBMCs were treated with 5% normal mouse serum (NMS),
stained with an antibody mixture consisting of anti–CD19-
allophycocyanin-Alexa Fluor700, anti–CD27-allophycocyanin,
anti–CD43-FITC, anti–CD38-PerCP-Cy5.5, anti–CD20-
Pacific Blue, anti–CD3-PE-TexasRed, anti–CD4-PE-TexasRed,
and anti–CD7-PE-TexasRed in cell-sorting buffer, and then
stained with Aqua Live/Dead dye (Invitrogen). Fluorescence
Minus One controls were used for CD43+ and CD27+
cell selection. After washing, cells were resuspended in cell-
sorting buffer and sort-purified on an Influx instrument
(BD). B-1 (CD19+CD20+CD27+CD38low/intCD43+) cells
were collected from the CD3/4/7 negative population as
previously described (20), following the gating strategy
represented in Supplementary Figure 1A. The average
purity of purified B-1 cells post-sort was 85%. For
single-cell antibody sequencing, purified B-1 cells were
re-sorted immediately after the initial sort, according to
CD19+CD20+CD27+CD38low/intCD43+ expression applying
FSC-H/FSC-W-based doublet discrimination and single sort
mask settings (Supplementary Figure 1B).
Flow Cytometry
Single-cell suspensions of PBMCs were pre-incubated with
NMS for 20min and then labeled for 30min at 4◦C with
the following antibodies in FACS buffer: anti–CD19-Alexa
Fluor 700, anti–CD20-Pacific Blue, anti–CD3-PE-TexasRed,
anti–CD4-PE-TexasRed, anti–CD7-PE-TexasRed, anti–CD27-
allophycocyanin, anti–CD38-PerCP-Cy5.5, anti–CD43-
allophycocyanin-Alexa Fluor 750, and Aqua Live/Dead
dye. Expression of cell surface markers was analyzed with a
Gallios flow cytometer and FlowJo Software v. 9.7.6 (Tree
Star). Antibodies were purchased from Beckman Coulter, BD
Biosciences, or Biolegend.
Enzyme-Linked Immunospot Assay
(ELISPOT)
ELISPOT assays were used to detect antibody-secreting cells.
Sort-purified cells (1–10 x 103) were distributed on Multi-
Screen-IP Plates (Millipore) precoated with goat anti–human
IgM or goat anti–human IgG and then incubated in complete
medium (RPMI medium supplemented with 10% FCS, 10mM
HEPES, 1mM non-essential aminoacids, 2mM L-glutamine,
1mM pyruvate, and 50µg/mL Penicillin/Streptomycin) for 18 h
at 37◦C and 5% CO2. Plates were then incubated with alkaline
phosphatase-conjugated goat anti-human IgM or anti-human
IgG (Southern Biotech), and developed with VECTOR Blue,
Alkaline Phosphatase Substrate Kit III (Vector Laboratories).
Immunoglobulin-secreting B cells were enumerated using C.T.L
ImmunoSpot software (Cellular Technology Limited).
Wright-Giemsa Staining
B-1 cell morphology was analyzed immediately after sorting by
cytospin andWright-Giemsa staining (Sigma-Aldrich) according
to the manufacturer’s protocol. Images were acquired on a Nikon
E80i microscope or a Zeiss LSM 710. ImageJ/Fiji software was
used for analysis.
Real Time PCR
Total RNA from sort-purified B-1 cells was isolated using RNeasy
(QIAGEN). cDNA synthesis was achieved using iScript (BioRad)
according to the manufacturer’s protocol. Quantitative PCR
reactions were conducted in anABI 7,300machine using reagents
and primers (Taqman) from Life Technologies. Primers: GAPDH
Hs02758991_g1, Blimp-1 (PRDM-1) Hs00153357_m1, XBP-1
Hs0231936_m1, and PAX-5 Hs00277134_m1.
Single-Cell RT-PCR and IGHM Analysis
Single cells were sorted into 96-well PCR plates containing 20
uL/well of ice-cold lysing buffer (40 U/µl RNaseOut, 0.1M
DTT, 0.4% IGEPAL, 1 mg/ml carrier RNA, and 1xRTIII buffer
in dH2O), as previously reported (20). cDNA was synthesized
in the original sorting plate in a final volume of 22.75 µl using
SuperScript III RT (200 U/µl), random hexamers (50µM),
and dNTP mix (10mM). Reverse transcription (RT) was
performed at 42◦C for 10min, 25◦C for 10min, 50◦C for
60min, and 94◦C for 5min as described by Tiller et al. (46).
IgH gene transcripts were amplified by two rounds of nested
PCR. Protocol and primers were adapted from Tiller et al. (46).
Two or more sequences were considered part of a clonotype if
there was 100% homology in the CDR-H3 aminoacid sequence.
The sequencing data have been submitted to the National
Center for Biotechnology Information’s Genbank (http://
www.ncbi.nlm.nih.gov/genbank/) under accession numbers
MK433645–MK434149.
Statistics
Statistical analysis was carried out with GraphPad Prism 6.0
and SPSS 16.0 software. To examine differences between two or
more groups, Mann-Whitney U-test and Dunn’s test were used,
respectively. To examine the relationships between two variables,
Spearman’s correlation analysis was performed. P-values for IgH
gene repertoire analysis were calculated by Fisher’s Exact Test and
Chi-square test. Error bars represent standard error of the mean
(SEM) unless otherwise indicated.
RESULTS
Human B-1 Cells Decline With Advancing
Age
The proportion of naïve and memory subsets within the human
B cell compartment has been extensively studied [Reviewed in
(47)]. However, data on age-related changes in the human B-1 cell
(CD19+CD20+CD27+CD38low/intCD43+) population remain
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scarce. Here, we analyzed total CD19+ B cells and B-1 cells
in the peripheral blood of 87 healthy donors of different ages
(20–88 years). We found that the percentage of total CD19+ B
cells as a fraction of total lymphocytes significantly decreased
with advancing age (Figure 1A and Supplementary Figure 2A),
consistent with previous reports (48–52). Importantly, we found
the fraction of B-1 cells in the total CD19+ B cell population
significantly declined with increasing age (Figure 1B). After
analyzing various regression models, we found our data do not
follow a linear regression trend and instead are better fit by a
cubic model (higher R-squared). B-1 cell percentages were also
compared grouping samples from donors within different age
ranges. This analysis confirms a decrease in B-1 cell frequency
with aging, which starts to be significant after the age of 50
(Supplementary Figure 2B). Thus, with advancing age, B-1 cells
decline as a fraction of the declining total B cell population.
Human B-1 Cell Spontaneous Antibody
Secretion Declines With Advancing Age
One of the most important functions of B-lymphocytes is their
ability to secrete antibodies. B-1 cells spontaneously secrete IgM
and IgG antibodies, which are essential to fight infection (10, 43,
53), and have been related to the pathology of autoimmunity and
other diseases (54, 55). Therefore, we investigated whether the
ability of B-1 cells to spontaneously secrete antibodies changes
with increasing age. Circulating B-1 cells from young (20–45
years) and old (65–88 years) donors were sort-purified and
examined for spontaneous IgM and IgG secretion by ELISPOT
assay. B-1 cells from both young and old donors spontaneously
secreted IgM and IgG antibodies (Figures 2A,B). However, the
percentage of B-1 cells spontaneously secreting IgM significantly
decreased in old age compared with the young group while
the frequency of IgG-secreting B-1 cells from older donors was
no different from that of younger donors (Figure 2B). We also
compared the amount of IgM or IgG secreted by each individual
B-1 cell by calculating mean spot size. B-1 cells from young and
old donors secreted similar amounts of IgM per secreting cell
(Figure 2C). In contrast, on average, B-1 cells from older donors
spontaneously secreted less IgG per secreting cell, compared
with B-1 cells from younger individuals (Figure 2C). Thus, the
age-related loss of B-1 cells (Figure 1) includes disproportionate
loss of IgM-secreting B-1 cells and impaired secretion by an
unchanging number of IgG producing cells (Figure 2).
Human B-1 Cell Expression of Secretory
Genes Changes With Advancing Age
Immunoglobulin secretion by conventional B-2 cells is controlled
by a set of transcription factors including B lymphocyte inducer
ofmaturation program 1 (Blimp-1) encoded by the PRDM-1 gene
locus, Xbox binding protein-1 (XBP-1), and paired box gene 5
(PAX-5) (56). The mechanism of spontaneous immunoglobulin
secretion by B-1 cells is only partially understood. However,
some of these transcription factors have been shown to be
involved in both mouse and human B-1 cell secretion (57, 58).
To gain insight into the mechanism underlying downregulation
of B-1 cell antibody secretion in aging, we determined whether
B-1 cells from old donors exhibit alteration in expression of
genes associated with antibody secretion by quantitative RT-PCR,
as compared to B-1 cells from young donors. We found the
expression levels of Blimp-1 (PRDM-1) and XBP-1, that promote
immunoglobulin secretion, were significantly lower in the B-1
cell population isolated from old donors in contrast with B-1 cells
from young donors (Figure 3). Further, with advancing age B-
1 cells expressed increased levels of PAX-5, an inhibitor of the
immunoglobulin secretory phenotype (Figure 3). Thus, the age-
related impairment in B-1 cell immunoglobulin secretion could
be related to age-related changes in expression of genes that
regulate antibody secretion.
Human B-1 Cell Morphology Changes With
Advancing Age
Antibody secreting cells or plasma cells are characterized by
a small, dense eccentrically placed nucleus and prominent
cytoplasm, with abundant rough endoplasmic reticulum (RER)
and enlarged Golgi. In contrast, non-secreting mature B cells
have a high nucleus to cytoplasm ratio, little RER, and an
FIGURE 1 | Human B-1 cells decline with advancing age. PBMCs isolated from 87 healthy donors (20–88 years) were analyzed by flow cytometry for total CD19+ B
cells (A) or B-1 cells (CD19+CD20+CD27+CD38low/intCD43+) (B). (A,B) Data plotted in each diagram represent CD19+ B cells given as percent lymphocytes (A)
and B-1 cells given as percent CD19+ B cells (B), each as a function of donor age. Spearman’s r for each correlation and significance are the following: CD19+ B
cells: r = −0.2997, p = 0.0053; B-1 cells: r = −0.3351, p = 0.0015. The solid line through the data points refers to a cubic regression curve fit.
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FIGURE 2 | Human B-1 cell spontaneous antibody secretion declines with advancing age. Sort-purified circulating B-1 cells were plated and analyzed for
spontaneous IgM and IgG secretion by ELISPOT. (A) ELISPOT images corresponding to four different representative donors (2 young and 2 old) are shown. Each
sample was tested in duplicate. The number of cells that were plated in each well is indicated. (B) Plots show the frequency of IgM- or IgG-secreting B-1 cells from
young (n = 10–18) and old (n = 8–11) donors measured and analyzed by ImmunoSpot software. (C) Plots show the mean spot size of IgM- or IgG-secreted
antibodies for each young (n = 9–18) or old (n = 8–10) donor. *p < 0.05 by Mann–Whitney U-test, bars are standard errors of the means (SEM).
uncondensed nucleus (59–61). To determine whether age-
related changes in B-1 cell antibody secretion are reflected
in morphological alterations, we examined the appearance of
B-1 cells obtained from healthy young and old donors. We
found that B-1 cells from young donors displayed morphologic
characteristics typical of antibody-secreting cells, such as
abundant cytoplasm and a small nucleus. On the other hand,
the morphology of B-1 cells from old donors is closer to that
of non-secreting B cells with a high nucleus to cytoplasm
ratio (Figures 4A,B). Further, the frequency of B-1 cells with
a lower nucleus to cytoplasm ratio is higher in each young
donor as compared to each old donor (Figure 4C). These results
are consistent with results obtained from ELISPOT and gene
expression assays, and all together indicate cell-intrinsic defects
in the immunoglobulin secretory pathway of B-1 cells accumulate
with advancing age.
Effect of Age on the IgM IGHV Gene
Repertoire of Circulating Human B-1 Cells
In humans, the general B cell repertoire of older individuals
is characterized by decreased clonal diversity, reduced levels
of mutation, and persistent clonal expansions (32, 62, 63).
Although the B-1 cell repertoire in particular has been shown
to significantly change with age in mice, little is known about
equivalent changes in humans. Considering this, we studied age-
related changes in the IgM B-1 cell repertoire in healthy humans
of young and old age.
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FIGURE 3 | Human B-1 cell expression of secretory genes changes with advancing age. B-1 cells from PBMCs were sort-purified and analyzed by RT-PCR for gene
expression. The panels represent the relative expression of transcription factors related with B-cell secretory phenotype for 9–10 young and 7–8 old donors,
normalized to GAPDH. *p < 0.05, **p < 0.01 by Mann–Whitney U-test, bars are mean and standard error of the mean (SEM).
We single cell sorted circulating B-1 cells and amplified IgM
heavy chain (IGHM) genes. A total of 572 sequences were
generated from ten young (20–45 years) and ten old healthy
donors (65–88 years). After quality control to ensure only
productive, full-length sequences were represented, we obtained
a total of 508 IgM sequences: 193 sequences for the young group
and 315 sequences for the old group. Overall, a total of 384 unique
V(D)J gene rearrangements were identified after heavy chain
complementarity determining region 3 (CDR-H3) clustering. Of
the 193 sequences obtained from young B-1 cells, 186 were
unique sequences (93.6%), while of the 315 sequences obtained
from old B-1 cells, 198 were unique sequences (62.8%) (Table 1).
The median B-1 cell sequence/clone ratio among young donors
was 1.05, with individual values ranging from 1.0 to 1.13
(Figure 5A). In the old donors, however, the sequence/clone
ratio was significantly higher, with a median value of 2.11 with
individual ratios ranging between 1.0 and 5.90 (Figure 5A).
Considering individual donors, only 2 out of 10 B-1 cell samples
from young donors had at least one expanded clonotype whereas
7 out of 10 B-1 cell samples from old donors had at least one
expanded clonotype.
Among young donors, we found 3 clones shared between
different individuals while in old donors we did not find any
clonotype sharing. Further, four clones were shared between
young and old donors. Three out of these four clones were part
of expanded clonotypes in either young or old B-1 cells (Table 2).
The IgH CDR-H3 tree maps show that B-1 cells from young
donors had a highly diverse repertoire (Figure 5B). In contrast,
CDR-H3 sequences expressed by B-1 cells from old donors
were less diverse and recurred more frequently (Figure 5B). The
recurrent CDR-H3 aminoacid sequences for both age groups are
summarized in Table 2. Taken together, these data indicate that
the B-1 cell IgHM repertoire changes with age and becomes more
restricted and repetitive as compared to younger individuals,
whose repertoire is more diverse.
We quantified the frequency of IGHM sequences expressing
individual VH, DH, and JH genes for each sorted B-1 cell sample
and then compared the usage of these segments between young
and old donors. From this point onward, only one representative
sequence per clone was used for analysis to reduce the influence
of clonal expansion on the VH, DH, and JH gene usage profile.
We found B-1 cells from both young and old donors were similar
in expressing mainly genes from the IGHV3 family as previously
described for this B cell population (20). We also found similarity
in use of the IGHD2, IGHD3, and IGHD6 families and the
IGHJ4 gene family by B-1 cells from both young and old donors
(Figure 6A). However, B-1 cell IgM sequences from old donors
differed from those of young donors, at the gene family level, in
increased use of IgHD3 and IgHJ2.
Further analysis of the young and old B-1 cell repertoires
focused on individual gene segments (Figure 6B). An analysis of
individual IGHV and IGHD genes showed a significant increase
in IGHV3-53 and IGHD2-8 usage and a significant decrease in
IGHV3-48, IGHD5-12, and IGHD6-6 usage with increasing age
(Figure 6B). Thus, we identified some changes in IGHM gene
segment usage associated with aging, both at the family and the
individual gene level, although the significance of these changes
within the context of the overall aging repertoire in terms of
binding and function are at present unknown.
The CDR-H3 of immunoglobulin molecules is critical for
specificity and affinity (64), so alterations in CDR-H3 properties
could reflect selection for certain antigens. We compared CDR-
H3 characteristics in IGH sequences from young and old B-1
cells. N-region addition provides junctional diversity to the CDR-
H3 region through the addition of random nucleotides. Mouse
B-1 cell antibodies have few N-additions early in life due to the
lack of TdT enzyme during fetal B cell development, but later in
life mouse B-1 cell antibodies contain N-additions (45). Human
B cells possess N-additions due to constitutive expression of TdT
as soon as 12 weeks after gestation (65) but changes with age in
human B-1 cells have not been studied. We analyzed N-addition
at the D–J and V–D junctions in B-1 cell antibodies from young
and old donors. We found only a few antibody sequences did not
have any N-addition at either junction (2–4%) and most of the
sequences presented more than one N-addition at both junctions
(>74%) (Figure 7A). No significant differences were found in the
number of N-additions between young and old B-1 cell antibody
sequences. We further examined CDR-H3 length and found old
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FIGURE 4 | Human B-1 cell morphology changes with advancing age. B-1 cells were sort-purified from PBMCs and stained with Wright–Giemsa stain. (A)
Representative photomicrographs of B-1 cells from a young and an old donor are shown (magnification 60X). (B) Median nucleus/cytoplasm ratios of B-1 cells from
young and old donors are shown. The diameters of the nucleus and the cytoplasm were measured by ImageJ software. Each dot represents the median of the
nucleus/cytoplasm ratios calculated for each individual donor from the cells in 5–10 fields. *p < 0.05 by Mann–Whitney U-test, bars are means and standard errors of
the means (SEM). (C) Frequency distributions of nucleus/cytoplasm ratios in B-1 cells from five young and 3 old donors are shown.
B-1 cell antibodies hadmore CDR-H3 with 13 and 15 aminoacids
while young B-1 cell antibodies presented more CDR-H3 with 11
and 14 aminoacids (Figure 7B). However, the average CDR-H3
length did not differ significantly between young and old B-1 cell
antibodies (p= 0.3570).
B-1 cell IgM antibodies have been shown to have SHM
both in mice and humans. Further, the Herzenberg group
has found that in mice both splenic and peritoneal B-1 cells
accumulate SHM in the IgM repertoire as the animal age (35).
Taking this into consideration, we hypothesized that the same
might be happening in human B-1 cells. We analyzed somatic
hypermutation in B-1 cell antibodies from young and old donors.
We found a high percentage of B-1 cell antibody sequences from
both young and old donors displayed more than one nucleotide
mutation. B-1 cell antibodies without any mutation appear to be
less frequent in older as compared to younger donors; further, B-1
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cell antibodies with 10 or more mutations tend to be increased
in the old group, but this difference did not reach the level of
significance (Figure 7C). All together, these results suggest the
structure of B-1 cell derived IgM does not change with age,
although IgM repertoire diversity decreases significantly.
DISCUSSION
Previous studies have shown that aging is characterized
by significant changes in total B cells and some B cell
subpopulations, resulting in age-related changes in antibody
composition. However, little is known regarding age-related
changes in human B-1 cells. The human B-1 cell phenotype
has evolved over time. Early studies suggested that similar to
mice, human B-1 cells express CD5 and are present at a higher
frequency in human umbilical cord blood and fetal spleen than
in adult peripheral blood and spleen (66). Further, human CD5-
expressing B cells were reported to produce autoreactive IgM
antibodies and to be increased in patients with autoimmune
diseases (67, 68). However, CD5 is also present at a variable extent
on different human B-cell populations, including transitional,
TABLE 1 | Numbers of IGHM sequences produced by single-cell PCR.
Young (10 donors) Old (10 donors)
Total IGHM sequences* 193 315
Unique IGHM rearrangements#s 186 198
Sequence/clone ratio† 1.04 1.59
*The numbers represent the total of IGHM sequences that passed quality control with
full immunoglobulin V(D)J gene rearrangement. #The numbers refer to unique sequences,
where only one example per clone is counted. Two sequences were considered part of a
clonotype if there was a 100% homology in the CDR-H3.
†
Represents the total number
of IGHM sequences of all the young or old donors divided by the number of unique
IGHM rearrangements.
pre-naïve, and activated B-cells (69–71). Further, not all B-1 cells
in mice express CD5, as is the case of B-1b cells, suggesting
that CD5+ alone is not sufficient to designate the human
B-1 cell population. More recently, Griffin et al. proposed a
novel phenotype for B-1 cells (CD20+CD27+CD43+) based on
the fact that the population so defined fulfills key functional
criteria for B-1 cells such as spontaneous antibody secretion
(19). Since then, several independent groups have evaluated this
circulating B cell population in healthy volunteers, during human
fetal hematopoietic development, and in clinical conditions of
common variable immunodeficiency, multiple sclerosis, bone
marrow transplantation, and lupus (21, 22, 72–74). Here, we
identified human B-1 cells as CD19+CD20+CD27+CD38low/int
CD43+, according to the more detailed phenotypic profile
recently described by Quach et al. (20). In the present study,
we found similar percentages of circulating B-1 cells to the ones
reported before for this population (20, 22, 23). Although this is
a small percentage, similar B-1 frequency has been detected for
mouse splenic B-1 cells (75), which are responsible for most of
the spontaneous IgM secretion in mice. In fact, we found that the
circulating B-1 cells in humans are able to spontaneously secrete
immunoglobulin and thus are likely to contribute to the natural
antibody pool.
Our results show the percentage of B-1 cells within the total
CD19+ B cell population decreases with advancing age. The age-
related decline we detected in the human B-1 cell population as
a fraction of total B cells is even more striking if the age-related
decrease in total CD19+ cells is taken into account. This result
is opposite to what has been observed in mice where B-1 cell
number increases or remains unchanged with age (76). Mouse
B-1 cells arise early in life from embryonic and fetal progenitors
and are maintained later on by self-renewal and an unknown
level of production from adult bone marrow precursors (45, 77–
79). These processes appear not to be affected in a quantitative
way in aged mice. Although little is known about human B-1
cell ontogeny, a recent report by Quach et al. showed human B-1
FIGURE 5 | Human B-1 cell antibody diversity declines with advancing age. Single B-1 cells were sorted into 96-well plates, and IgM heavy chains (IGHM) were
individually amplified for sequence analysis. IGHM genes were analyzed by IMGT V-QUEST and then clustered into clones by CDR-H3 DNA sequence similarity. (A)
The total number of IGHM sequences of each donor sample divided by the number of unique IGHM rearrangements in the same sample (sequence/clone ratio) is
shown for B-1 cell antibodies from young and old donors. *p < 0.05 by Mann–Whitney U-test, bars are means and standard errors of the means (SEM). (B) Tree map
representation of IGHM repertoires from B-1 cells isolated from young (20–45 years) and old (65–88 years) donors, where each rectangle represents a unique V(D)J
rearrangement and the area of each rectangle denotes the relative frequency of an individual sequence. Each graph represents the frequency of IGHM clonotypes in
the B-1 cell pool from all the young (n = 10) or all the old (n = 10) donors. The numbers shown inside the rectangles indicate the sizes of the clones.
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TABLE 2 | Recurring CDR-H3 sequences (peptide and V(D)J recombination) in B-1 cells from young and old donors.
IGHM CDR3 sequences
Occurrence† Peptide V(D)J
YOUNG (20–45 YEARS) (n = 10) 1 2 ARAQGSSVDY V3-21 D2-15 J4
2 2 ARALGYYDSSGYDLPRIDY* V3-13 D3-22 J4
3 2 ARDPFADYLDY$* V3-74 D3-10 J4
4 2 ARDWDSSSRDYYGMDV* V3-21 D6-13 J6
5 2 ARGDPTLSSSSPLDY V4-34 D6-6 J4
6 3 AKDIGYTSSSGFDY$* V3-9 D6-6 J4
OLD (65–88 YEARS) (n = 10) 1 2 AKDEGGGSGWPHYYYQYMDV V3-9 D6-19 J6
2 2 ARDQGSGSLHY V1-3 D3-10 J4
3 2 AREWLSNSYYYGMDV V3-21 D3-22 J6
4 2 AREYSSGWHFDY V1-3 D6-19 J4
5 2 ARGGGNWGYYFDS V4-34 D4-23 J4
6 2 ARGNYYGSGSYYFDS V3-7 D3-10 J4
7 2 ARKIVGATGDDGMDA V4-34 D1-26 J6
8 2 VRDAGTGYLDY V3-30 D5-24 J4
9 3 ARGGGSPGYSYEFDY V4-34 D5-18 J4
10 3 ARHSGWYPYYYMDV V4-38 D3-10 J6
11 3 ARSSRYGDYLDAFDI V3-53 D4-17 J3
12 3 ARWDCSSTSCVDY# V3-30 D2-2 J4
V3-15 D6-13 J2
13 4 AKAAYGDYVSTYFDY V3-30 D4-17 J4
14 4 AREAFYCTNGLCYLNF V1-46 D2-8 J4
15 4 VRDGWGATSNNWFDP# V3-7 D1-26 J5
V3-15 D6-13 J2
16 5 AMVGYYDTSGQSLDY V1-18 D3-22 J4
17 5 TTDLPVADYFQY V3-15 D6-19 J1
18 6 ARGDCRGGGCQSHFDS$ V3-33 D2-15 J4
19 6 GTDSGAFDM V3-73 D3-10 J3
20 11 ARDAIIQYDC V3-7 D2-8 J4
21 28 TTVGSGSWFSWYFDL# V3-15 D6-13 J2
V1-8 D6-13 J2
V3-7 D1-26 J5
V3-21 D3-22 J4
V3-30 D3-3 J6
V4-38 D5-18 J4
22 38 AGRGLYYDFWSGSTTDYYYMDV V4-34 D3-9 J6
†
Times a CDR-H3 aminoacid sequence is present in the repertoire of all young or old donors. #The same CDR-H3 aminoacid sequence was encoded by different V(D)J recombination.
$Clonotype sharing between B-1 cell repertoire from young and old donors. *Clonotype sharing between B-1 cell repertoire from more than one young (*).
cells develop from umbilical cord blood Lin-CD34+CD38lo stem
cells after adoptive transfer to immunodeficient (NSG) mice.
However, in the same study Lin-CD34+CD38lo stem cells from
adult bone marrow were much less effective in giving rise to B-1
cells (80). The frequency of common lymphoid progenitor cells
(81) and, in particular, B cell progenitors (82) has been reported
to decrease with age, and human hematopoietic stem cells from
old donors, xenotransplanted into immunodeficient mice, do not
generate lymphoid progeny as efficiently as stem cells from young
donors (81). All together, these findings indicate that poor bone
marrow production may be responsible, at least in part, for the
age-related decline in total B cells. Thus, poor production of B-1
cells by human adult bone marrow progenitors may contribute to
the decline in B-1 cell numbers with advancing age, and/or fail to
compensate when B-1 cell numbers decline for other reasons.
It has been shown that aging affects not only the frequency
but also the function of B cells (51). The main function of B-1
cells is the spontaneous secretion of antibody. Our results show
this important function is adversely affected by age.We found the
frequency of spontaneously IgM-secreting B-1 cells was reduced
among B-1 cells obtained from old donors as compared to young
donors. However, age did not affect the IgM secretion capacity
of each individual B-1 cell, which was not impaired. Conversely,
the frequency of spontaneously IgG-secreting B-1 cells didn’t
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FIGURE 6 | VH, DH and JH gene segment usage frequencies within B-1 cells from young and old donors. Gene usage was calculated as the percentage of the total
unique sequences for all the clones from young (n = 10) and old (n = 10) donors. From each clonotype only one representative sequence was considered for analysis.
Relative frequencies of IGHV, IHGD, and IGHJ gene family (A), and individual IGHV and IGHD gene segment (B) usage are represented. ↑indicates a significant
increase in IGHD or IGHJ gene family usage in the old B-1 population compared to the corresponding frequency in young B-1 cells. *p < 0.05, **p < 0.01,
***p < 0.001 by χ2 test or exact Fisher’s test.
change as a function of age, but an age-related defect of each
spontaneously IgG-secreting B-1 cell was apparent, resulting in
less immunoglobulin production per cell. These results might
suggest that themechanism for spontaneous secretion of IgM and
IgG by human B-1 cells is different and is affected differently by
the aging process.
The mechanism underlying spontaneous secretion of natural
antibodies by B-1 cells is not fully understood. Induction of
Blimp-1 is one of the first steps required for the generation of
antibody secreting plasma cells in mice and in humans (83–
85). It has been reported that the mouse B-1 cell subpopulation
spontaneously secretes antibodies by mechanisms that are both
dependent on, and independent of, Blimp-1, and that work
differently for IgM and IgG secretion. Savage et al. demonstrated
that splenic B-1 cells spontaneously secreting natural antibodies
are a heterogeneous population that contains both Blimp-1-
positive B-1 cells and Blimp-1-negative B-1 cells. While both
subsets secrete natural IgM, spontaneous IgG3 secretion by B-1
cells was mostly Blimp-1–independent, suggesting an alternative
activation/differentiation pathway is used by Blimp-1-negative
antibody-secreting cells (58). The mechanism of spontaneous
immunoglobulin secretion by human B-1 cells has not been
studied; thus, it is unknown whether mice and humans
share similar pathways, nor whether human B-1 represent a
heterogeneous population regarding the dependency on Blimp-
1 for spontaneous secretion. A previous paper by Quach et al.
reported that human B-1 cells express substantial levels of
Blimp-1 (20), suggesting the importance of this molecule for
spontaneous secretion by human B-1 cells. Our results showed
that the level of Blimp-1 expression is lower in old B-1 cells
as compared to young B-1 cells. Thus, the level of Blimp-1
could be related to a decrease in the frequency of B-1 cells that
spontaneously secrete IgM and/or to the fact that old B-1 cells
secrete less IgG antibody per cell. The difference we found in
the behavior of IgM or IgG secreting B-1 cells with age may be
explained by the existence of different pathways for IgM and IgG
spontaneous secretion, as was reported for mice.
Blimp-1 deficiency during aging has been reported previously.
Frasca et al. found a decrease in Blimp-1 expression in general
CD19+ cells after 5–8 days of stimulation with CpG (86). In
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FIGURE 7 | Characterization of the CDR-H3 region in the B-1 cell IGHM repertoire. B-1 cells from 10 young and 10 old donors were single cell sorted and the IgM VH
regions were amplified and sequenced. From each clonotype only one representative sequence was considered for analysis. (A) N-region addition analysis of B-1 cell
IgM from young and old donors. The percentages of sequences with zero N-additions at both junctions, one or more N-additions at both junctions, zero N-additions
at V-D and one or more at D-J junctions, or zero N-additions at D-J and one or more at V-D junctions are shown. (B) Length distribution of complementarity
determining region 3 (CDR-H3) is shown for B-1 cell IgM antibodies from young and old donors. Inset shows the distribution of individual CDR-H3 length from young
and old donors (C) The distribution of somatic mutations for B-1 cell IgM antibodies from young and old donors is shown as percent of sequences with zero or more
than one nucleotide mutation. Inset shows the distribution of mutations for each sequence from young and old donors. n.s. p > 0.05 by Mann–Whitney U-test.
contrast, in our study we show a significant decrease of Blimp-
1 expression in non-stimulated B-1 cells from old individuals
compared with young. Our results may represent a defect in
the spontaneous/basal expression of Blimp-1 in old B-1 cells
which may explain their decreased capacity to spontaneously
secrete immunoglobulin. Expression of 2 additional genes tied
to antibody secretion also correlated with age-related diminution
of B-1 cell antibody secretion: loss of XBP-1 and gain of
PAX-5. As XBP-1 is under PAX-5 control and at the same
time PAX-5 is regulated by Blimp-1, the difference in the
expression levels of the former transcription factors in B-1 cells
from old donors may in turn be explained by the observed
decrease of Blimp-1 levels. The reason for decreased Blimp-1
mRNA expression in B-1 cells from old as compared to young
donors could be due to up-regulation of Blimp-1 repressors
(Bach2/MITF) and/or an age-associated down-regulation of the
mRNA stability of Blimp-1. In both scenarios, micro-RNAs and
other epigenetic modifications may be involved (87), given the
fact that epigenetic regulation dramatically changes with age
(88, 89) including in the B cell compartment (90, 91). Regardless
of the molecular mechanism, with advancing age spontaneous
natural antibody secretion by B-1 cells is reduced, in terms of
the number of IgM-secreting B-1 cells and the amount of IgG
secretion per cell. Further confirmation of age-related alteration
in immunoglobulin secretion is provided by morphological
changes that include increased nuclear/cytoplasmic ratio in old
vs. young B-1 cells.
Next, we further analyzed B-1 IgM antibody repertoire
changes during aging. We focused our study on IgM since
natural antibodies with this isotype are the ones that have
been extensively associated with natural protection against
several diseases, many of which are more prevalent in the
elderly, and have been associated with homeostatic control in
numerous studies in mice and humans (10, 92–96). Beside a
cell intrinsic defect in spontaneous immunoglobulin secretion,
we found a reduction in IgM antibody heterogeneity among
B-1 cells from old donors. There was an increase in the
number and size of clones, and a corresponding decrease
in the number of unique sequences with advancing age.
Previously, Gibson et al. showed that repertoire diversity of
total B cells decreases with age and is associated with poor
health (32). However, until now there has been no information
on the degree to which human B-1 cells participate in this
change. In mice, certain splenic B-1a VDJ sequences become
progressively more dominant with age (35), and peritoneal
B-1a IgM antibody sequences acquire increased levels of N-
addition in old animals (43, 45). The origin of these changes
in the mouse B-1a repertoire remains unproven but may well
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result from antigen selection (35, 97, 98). The same may be
true of human B-1 cell antibodies. That is, clonal expansion
in old individuals may be an adaptive response to recurrent
exposure to specific antigens. The decreased diversity of the
B-1 cell IgM repertoire in old people might contribute to the
weakness of natural antibodies in defense against infections of
this population.
Two clones among old B-1 cell antibodies were particularly
large (38 and 28 members, respectively). However, because each
appeared in only one donor, we consider these subject-specific
clones, and it cannot be concluded that these clones represent
specificities that are generally increased across the population of
older donors. Regardless, it would be of interest to determine the
specificities that triggered expansion of these clones. Although
definitive information is not available, it is notable that clone
22 (as refered in Table 2) shared 88% identity with an antibody
reported in a study about human natural autoantibodies reacting
with the α-subunit of the human high-affinity immunoglobulin E
(IgE) receptor (FcεRIα) (99).
Discounting clonal expansion, that is, focusing only on
unique sequences, there was very little difference in human
B-1 cell IgM antibodies from healthy old vs. healthy young
donors in terms of VH family usage. This is similar to the
situation with human naïve B cells but different than other
human B cell subsets (100), and may reflect continual self-
renewal of a population established early in life. However,
superimposed on this are several distinct differences in antibody
usage of individual VH segments between young and old
human B-1 cell antibodies, the origin and significance of which
remains uncertain.
Contrasting with mouse, in humans, TdT is expressed
throughout ontogeny (101). This explains the fact that newborn
antibodies from both B-1 and B-2 cells contain N-additions
(19, 65). This also might explain why we did not find any increase
in the number of N-additions in the old B-1 cell repertoire.
Further, the absence of an increased number of N-additions in
the elderly corresponds with the similar length of IgM CDR-
H3 in young and old B-1 cell antibodies. Although previous
reports demonstrated that the old IgM repertoire contains less
somatic mutation than the young (63), and that the function
of activation-induced cytidine deaminase (AID) is impaired in
old B cells as compared to young (51), we did not find any
change in the level of SHM in the human B-1 IgM repertoire
with age.
Overall our data show that the antibody repertoire of B-1
cells from healthy old individuals differs from that of healthy
young individuals in ways that restrict diversity. Together
with significant age-related decreases in B-1 cell frequency and
IgM/IgG secretion, age-related changes in B-1 cells likely impact
the quality of life of the older age population through loss of
natural antibody protection.
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Supplementary Figure 1 | Phenotypic analysis of human peripheral blood B-1
cells by flow cytometry. Lymphocyte-enriched peripheral blood samples were
stained with antibodies specific for human CD3, CD4, CD7, CD19, CD20, CD27,
CD38, and CD43, and with Aqua Live/Dead dye, and were analyzed by flow
cytometry. (A) Gating strategy to analyse and purify human B-1 cells is shown.
Lymphocytes were subjected to doublet discrimination. Singlet lymphocytes were
plotted to exclude CD3, CD4, and CD7 positive cells and to gate on CD19+ B
cells. B cells were plotted using CD20 in order to separate CD20+ B cells from
CD20- plasma cells. CD20+ B cells were plotted using CD27 and CD38 in order
to exclude CD38high pre-plasmablasts. CD38low/int were further resolved
according to CD27 and CD43 expression with B-1 cells being those cells
expressing both CD27 and CD43. Fluorescence Minus One controls were used
for CD43+ and CD27+ cell selection. (B) Post-sort analysis and gating strategy
for single-cell sorting is shown. For single-cell sorting, purified B-1 cells were
re-sorted immediately after the first sorting process according to CD19+CD20+
CD27+CD38low/intCD43+ expression applying FSC-H/FSC-W-based doublet
discrimination and single sort mask settings.
Supplementary Figure 2 | Human B-1 cells decline with advancing age. PBMCs
isolated from 87 healthy donors (20–88 years) were analyzed by flow cytometry for
total CD19+ B cells (A) or B-1 cells (CD19+CD20+CD27+CD38low/intCD43+)
(B). Distribution of B cells as percent of total lymphocytes (A) and B-1 cells as
percent CD19+ B cells (B) per age range. Different letters represent statistically
significant differences; p < 0.05, Kruskal-Wallis and Dunn’s tests.
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